Momenta Pharmaceuticals, Inc.
Sep 21, 2009

Momenta Pharmaceuticals to Present At the 2009 UBS Global Life Sciences Conference

CAMBRIDGE, Mass., Sep 21, 2009 (GlobeNewswire via COMTEX News Network) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that Richard P. Shea, Chief Financial Officer, will deliver a corporate presentation at the 2009 UBS Global Life Sciences Conference on Wednesday, September 23rd, at 2:00 pm EDT. The conference will be held at The Grand Hyatt New York.

A live audio webcast of the presentation will be available on the "Investors" section of the company's website located at www.momentapharma.com. A replay of the presentation will be posted on the Momenta website after the event and will be available through October 6th, 2009.

About Momenta

Momenta Pharmaceuticals is a biotechnology company, headquartered in Cambridge, MA, specializing in the detailed structural analysis of complex mixture drugs. Momenta is applying its technology to the development of generic versions of complex drug products, as well as to the discovery and development of novel drugs.

To receive additional information about Momenta, please visit the website at www.momentapharma.com, which does not form a part of this press release.

Our logo, trademarks, and service marks are the property of Momenta Pharmaceuticals, Inc. All other trade names, trademarks, or service marks are property of their respective owners.

This news release was distributed by GlobeNewswire, www.globenewswire.com

SOURCE: Momenta Pharmaceuticals

CONTACT:  Momenta Pharmaceuticals, Inc.
Investor Relations:
Beverly Holley
617-395-5189

(C) Copyright 2009 GlobeNewswire, Inc. All rights reserved.

News Provided by COMTEX